ReviewFrontiers in oncology2022

HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies.

Xin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.